Relmada Therapeutics Inc.

0.28
-0.01 (-2.10%)
At close: Apr 11, 2025, 9:35 AM

Relmada Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Jun 30, 2019 Jun 30, 2018 Jun 30, 2017
3.86M 4.09M 5.4M 44.44M 2.5M 36.28M 9.22M 2.24M 1.71M
41.05M 92.23M 142.93M 167.47M 114.6M 80.16M n/a n/a n/a
n/a n/a n/a n/a 86.38K n/a 203.14K 273.24K 337.73K
21.98K 43.13K 34.88K 28.29K 25K 190.99K 25K 24.79K 21.96K
n/a n/a 512.43K 86.38K 79.46K n/a 247.08K 72.1K 291.92K
n/a n/a 4.04M 11.3M 903.2K n/a 459K 426.9K 472.5K
886.46K n/a n/a n/a n/a 73.14K n/a n/a 125.19K
45.8M 97.51M 152.87M 223.3M 118.07M 116.94M 9.98M 2.74M 2.47M
n/a n/a n/a n/a 1.26K 5.01K 7.21K 12.08K 2.31K
n/a n/a n/a n/a n/a n/a n/a n/a n/a
21.98K 43.13K 34.88K 28.29K 112.64K 196K 235.35K 310.11K 362.01K
45.82M 97.55M 152.91M 223.33M 118.19M 117.14M 10.22M 3.05M 2.84M
4.13M 3.51M 5.26M 11.19M 8.35M 522.66K 924.36K 765.44K 529.56K
n/a n/a n/a n/a n/a n/a 1.32M 659.5K 394.6K
n/a n/a n/a n/a n/a 110.25K 364.2K 285.17K 276.67K
1.15M 5.68M n/a 0.00 n/a 250K -45 4.81M 513.55K
10.29M 12.19M 12.47M 15.06M 12.6M 1.46M 2.61M 5.9M 1.38M
n/a n/a n/a n/a n/a n/a n/a 2.66M n/a
4.47K n/a n/a n/a n/a n/a n/a n/a n/a
4.47K n/a n/a n/a n/a n/a n/a 2.66M n/a
10.3M 12.19M 12.47M 15.06M 12.6M 1.46M 2.61M 8.56M 1.38M
n/a n/a n/a n/a n/a 110.25K 364.2K 2.94M 276.67K
30.17K 30.1K 30.1K 27.74K 16.33K 14.46K 9.74K 3.14K 12.53K
-640.88M -560.9M -462.11M -305.07M -179.32M -119.86M -111.66M -94.34M -85.38M
n/a n/a -0.00 n/a 0.00 -0.00 n/a 0.00 n/a
35.52M 85.36M 140.44M 208.26M 105.58M 115.68M 7.61M -5.51M 1.46M
41.05M 92.23M 142.93M 167.47M 114.6M 80.16M 203.14K 273.24K 337.73K